![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 33, 29760-29764, August 16, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Glucosidase Gene Is a Novel Target of the
Notch-1/Hes-1 Signaling Pathway*
,
From the Arthritis and Rheumatism Branch, NIAMS, National
Institutes of Health, Bethesda, Maryland 20892-1820
Acid
-glucosidase (GAA) is a lysosomal enzyme
that degrades glycogen. A deficiency of GAA is responsible for a
recessively inherited myopathy and cardiomyopathy, glycogenosis type
II. Previously, we identified an intronic repressor element in
the GAA gene and demonstrated that Hes-1, a basic
helix-loop-helix factor, binds to a C class E box within the element
and functions as a transcriptional repressor in HepG2 cells.
Hes-1 is a well studied downstream target gene in the Notch
signaling pathway. In this study, over-expression and depletion of
Notch-1 intracellular domain (NICD) strategies were used to investigate
whether expression of the GAA gene is under the control of
Notch-1/Hes-1 signaling. In co-transfection experiments, Hes-1,
up-regulated by over-expressed NICD, enhanced the repressive effect of
the DNA element with wild type Hes-1 binding sites but not with mutant
Hes-1 binding sites. Conversely, depletion of Notch-1 with
phosphorothioated antisense oligonucleotides, corresponding to the
fourth ankyrin repeat within NICD, led to reduced Hes-1. Constitutively
over-expressed Hes-1 and Notch-1 repressed GAA gene
expression. Therefore, our data establish that the human
GAA gene, encoding a lysosomal enzyme, is a downstream target of the Notch-1/Hes-1 signaling pathway.
Current address: Dept. of Anatomy and Cell Biology, George
Washington University, Washington, D. C. 20037.
§
To whom correspondence should be addressed: Clinical Center, Bldg.
10, Rm. 9N244, NIAMS, National Institutes of Health, 9000 Rockville
Pike, Bethesda, MD 20892-1820. Tel.: 301-496-1474; Fax: 301-402-0012;
E-mail: plotzp@mail.nih.gov.
This article has been cited by other articles:
![]() |
J. Chen, A. Zacharek, A. Li, X. Cui, C. Roberts, M. Lu, and M. Chopp Atorvastatin Promotes Presenilin-1 Expression and Notch1 Activity and Increases Neural Progenitor Cell Proliferation After Stroke Stroke, January 1, 2008; 39(1): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Shen and S. Christakos The Vitamin D Receptor, Runx2, and the Notch Signaling Pathway Cooperate in the Transcriptional Regulation of Osteopontin J. Biol. Chem., December 9, 2005; 280(49): 40589 - 40598. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujimori, K. Kadoyama, and Y. Urade Protein Kinase C Activates Human Lipocalin-type Prostaglandin D Synthase Gene Expression through De-repression of Notch-HES Signaling and Enhancement of AP-2{beta} Function in Brain-derived TE671 Cells J. Biol. Chem., May 6, 2005; 280(18): 18452 - 18461. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Yeh, R.-H. Hsieh, S.-C. Shen, S.-H. Wang, M.-J. Tseng, C.-M. Shih, and J.-J. Lin Nuclear {beta}II-Tubulin Associates with the Activated Notch Receptor to Modulate Notch Signaling Cancer Res., November 15, 2004; 64(22): 8334 - 8340. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Yeh, Y.-M. Lin, R.-H. Hsieh, and M.-J. Tseng Association of Transcription Factor YY1 with the High Molecular Weight Notch Complex Suppresses the Transactivation Activity of Notch J. Biol. Chem., October 24, 2003; 278(43): 41963 - 41969. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fujimori, Y. Fujitani, K. Kadoyama, H. Kumanogoh, K. Ishikawa, and Y. Urade Regulation of Lipocalin-type Prostaglandin D Synthase Gene Expression by Hes-1 through E-box and Interleukin-1beta via Two NF-kappa B Elements in Rat Leptomeningeal Cells J. Biol. Chem., February 14, 2003; 278(8): 6018 - 6026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |